Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Medinotec (MDNC) Equity Average (2022 - 2025)

Medinotec filings provide 4 years of Equity Average readings, the most recent being $5.2 million for Q4 2025.

  • On a quarterly basis, Equity Average rose 93.03% to $5.2 million in Q4 2025 year-over-year; TTM through Nov 2025 was $5.2 million, a 93.03% increase, with the full-year FY2025 number at $3.2 million, up 36.31% from a year prior.
  • Equity Average hit $5.2 million in Q4 2025 for Medinotec, up from $4.6 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $5.2 million in Q4 2025 to a low of $1.2 million in Q2 2022.
  • Median Equity Average over the past 4 years was $2.6 million (2023), compared with a mean of $2.7 million.
  • Biggest five-year swings in Equity Average: soared 124.82% in 2023 and later dropped 14.71% in 2024.
  • Medinotec's Equity Average stood at $1.3 million in 2022, then skyrocketed by 73.5% to $2.3 million in 2023, then grew by 15.36% to $2.7 million in 2024, then surged by 93.03% to $5.2 million in 2025.
  • The last three reported values for Equity Average were $5.2 million (Q4 2025), $4.6 million (Q3 2025), and $4.3 million (Q2 2025) per Business Quant data.